A0FGR8 (ESYT2_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 29, 2013.
Version 67.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Extended synaptotagmin-2 Short name=E-Syt2 Alternative name(s): Chr2Syt | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 921 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | May play a role as calcium-regulated intrinsic membrane protein. Ref.1 |
| Subcellular location | |
| Tissue specificity | Widely expressed with high level in cerebellum. Ref.1 |
| Sequence similarities | Belongs to the extended synaptotagmin family. Contains 3 C2 domains. |
| Sequence caution | The sequence BAA91539.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally extended. The sequence BAC85769.1 differs from that shown. Reason: Frameshift at position 800. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Cell membrane Membrane |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Domain | Repeat Transmembrane Transmembrane helix |
| PTM | Phosphoprotein |
| Technical term | 3D-structure Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Cellular_component | integral to membrane Inferred from electronic annotation. Source: UniProtKB-KW plasma membraneInferred from electronic annotation. Source: UniProtKB-SubCell |
| Complete GO annotation... | |
Alternative products
| This entry describes 5 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: A0FGR8-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: A0FGR8-2) The sequence of this isoform differs from the canonical sequence as follows: 1-97: MTANRDAALS...RAPSPPRPGG → MTPPSRAEAG...GAGGAGGRAA | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 4 (identifier: A0FGR8-4) The sequence of this isoform differs from the canonical sequence as follows: 1-204: Missing. 706-731: PVIGGSDKPGMEEKAQPPEAGPQGLH → SQSRSRPPASPRTSRCPSPPRSCGKG 732-921: Missing. | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 5 (identifier: A0FGR8-5) The sequence of this isoform differs from the canonical sequence as follows: 1-593: Missing. 594-603: NPKRQDLEVE → MPVLPPCVLQ | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 6 (identifier: A0FGR8-6) The sequence of this isoform differs from the canonical sequence as follows: 550-550: S → SNPLEFNPDVLKKTAVQRALKS | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 921 | 921 | Extended synaptotagmin-2 | PRO_0000278258 | |||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||
| Transmembrane | 128 – 148 | 21 | Helical; Potential | ||||||||||||||||||||||||
| Transmembrane | 302 – 322 | 21 | Helical; Potential | ||||||||||||||||||||||||
| Domain | 372 – 473 | 102 | C2 1 | ||||||||||||||||||||||||
| Domain | 523 – 617 | 95 | C2 2 | ||||||||||||||||||||||||
| Domain | 788 – 892 | 105 | C2 3 | ||||||||||||||||||||||||
| Compositional bias | 736 – 739 | 4 | Poly-Ser | ||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||
| Modified residue | 691 | 1 | Phosphoserine Ref.14 | ||||||||||||||||||||||||
| Modified residue | 738 | 1 | Phosphoserine By similarity | ||||||||||||||||||||||||
| Modified residue | 739 | 1 | Phosphoserine Ref.14 | ||||||||||||||||||||||||
| Modified residue | 743 | 1 | Phosphoserine Ref.11 Ref.12 Ref.13 Ref.15 | ||||||||||||||||||||||||
| Modified residue | 748 | 1 | Phosphoserine Ref.14 | ||||||||||||||||||||||||
| Modified residue | 755 | 1 | Phosphoserine Ref.13 Ref.14 | ||||||||||||||||||||||||
| Modified residue | 758 | 1 | Phosphoserine Ref.12 Ref.13 Ref.14 Ref.15 Ref.17 | ||||||||||||||||||||||||
| Modified residue | 761 | 1 | Phosphoserine Ref.12 Ref.13 Ref.14 Ref.15 Ref.17 | ||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||
| Alternative sequence | 1 – 593 | 593 | Missing in isoform 5. | VSP_023236 | |||||||||||||||||||||||
| Alternative sequence | 1 – 204 | 204 | Missing in isoform 4. | VSP_023238 | |||||||||||||||||||||||
| Alternative sequence | 1 – 97 | 97 | MTANR…PRPGG → MTPPSRAEAGVRRSRVPSEG RWRGAEPPGISASTQPASAG RAARHCGAMSGARGEGPEAG AGGAGGRAA in isoform 2. | VSP_023239 | |||||||||||||||||||||||
| Alternative sequence | 550 | 1 | S → SNPLEFNPDVLKKTAVQRAL KS in isoform 6. | VSP_038324 | |||||||||||||||||||||||
| Alternative sequence | 594 – 603 | 10 | NPKRQDLEVE → MPVLPPCVLQ in isoform 5. | VSP_023240 | |||||||||||||||||||||||
| Alternative sequence | 706 – 731 | 26 | PVIGG…PQGLH → SQSRSRPPASPRTSRCPSPP RSCGKG in isoform 4. | VSP_023241 | |||||||||||||||||||||||
| Alternative sequence | 732 – 921 | 190 | Missing in isoform 4. | VSP_023242 | |||||||||||||||||||||||
| Natural variant | 210 | 1 | C → S. Corresponds to variant rs13233513 [ dbSNP | Ensembl ]. | VAR_030725 | |||||||||||||||||||||||
| Natural variant | 638 | 1 | S → G. Ref.3 Corresponds to variant rs2305473 [ dbSNP | Ensembl ]. | VAR_030726 | |||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||
| Sequence conflict | 141 | 1 | L → V in CAH10642. Ref.7 | ||||||||||||||||||||||||
| Sequence conflict | 612 | 1 | S → P in BAC85769. Ref.3 | ||||||||||||||||||||||||
| Sequence conflict | 615 | 1 | N → S in BAC86489. Ref.3 | ||||||||||||||||||||||||
| Sequence conflict | 795 | 1 | R → Q in BAC85769. Ref.3 | ||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||
| Beta strand | 789 – 797 | 9 | |||||||||||||||||||||||||
| Turn | 798 – 801 | 4 | |||||||||||||||||||||||||
| Beta strand | 802 – 811 | 10 | |||||||||||||||||||||||||
| Beta strand | 823 – 831 | 9 | |||||||||||||||||||||||||
| Beta strand | 835 – 837 | 3 | |||||||||||||||||||||||||
| Beta strand | 851 – 858 | 8 | |||||||||||||||||||||||||
| Helix | 862 – 867 | 6 | |||||||||||||||||||||||||
| Beta strand | 869 – 876 | 8 | |||||||||||||||||||||||||
| Beta strand | 889 – 894 | 6 | |||||||||||||||||||||||||
| Turn | 899 – 902 | 4 | |||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "E-Syts, a family of membranous Ca2+-sensor proteins with multiple C2 domains." Min S.-W., Chang W.-P., Suedhof T.C. Proc. Natl. Acad. Sci. U.S.A. 104:3823-3828(2007) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY. |
| [2] | Shan Y.X., Yu L. Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). |
| [3] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4 AND 5), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 511-921 (ISOFORMS 1/2), VARIANT GLY-638. Tissue: Esophageal carcinoma and Thymus. |
| [4] | "Human chromosome 7: DNA sequence and biology." Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K., Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R., Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A., Kanematsu E., Gentles S. Tsui L.-C.Science 300:767-772(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro." Nagase T., Ishikawa K., Kikuno R., Hirosawa M., Nomura N., Ohara O. DNA Res. 6:337-345(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 79-921 (ISOFORM 1). Tissue: Brain. |
| [6] | "Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones." Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T. DNA Res. 9:99-106(2002) [PubMed] [Europe PMC] [Abstract] Cited for: SEQUENCE REVISION. |
| [7] | "The full-ORF clone resource of the German cDNA consortium." Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 141-921. Tissue: Melanoma. |
| [8] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 454-921 (ISOFORM 6). Tissue: Colon. |
| [9] | "Genomic analysis of synaptotagmin genes." Craxton M.A. Genomics 77:43-49(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 747-904. Tissue: Brain. |
| [10] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [11] | "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra." Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D. J. Proteome Res. 6:4150-4162(2007) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-743, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [12] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-743; SER-758 AND SER-761, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [13] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-743; SER-755; SER-758 AND SER-761, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [14] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-691; SER-739; SER-748; SER-755; SER-758 AND SER-761, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [15] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-743; SER-758 AND SER-761, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [16] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [17] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-758 AND SER-761, MASS SPECTROMETRY. |
| [18] | "Solution structure of the third C2 domain of KIAA1228 protein." RIKEN structural genomics initiative (RSGI) Submitted (OCT-2006) to the PDB data bank Cited for: STRUCTURE BY NMR OF 222-350. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | DQ993201 mRNA. Translation: ABJ97706.1. AY368150 mRNA. Translation: AAR89381.1. AK001181 mRNA. Translation: BAA91539.1. Different initiation. AK124091 mRNA. Translation: BAC85769.1. Frameshift. AK126214 mRNA. Translation: BAC86489.1. CH236954 Genomic DNA. Translation: EAL23931.1. AB033054 mRNA. Translation: BAA86542.2. AL833233 mRNA. Translation: CAH10642.1. BC013957 mRNA. Translation: AAH13957.2. AJ303365 mRNA. Translation: CAC33887.1. | ||||||||||||
| IPI | IPI00409635. IPI00827663. IPI00827794. IPI00827920. IPI00953221. | ||||||||||||
| RefSeq | NP_065779.1. NM_020728.2. | ||||||||||||
| UniGene | Hs.490795. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | A0FGR8. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| IntAct | A0FGR8. 5 interactions. | ||||||||||||
| MINT | MINT-4541681. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | A0FGR8. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | A0FGR8. | ||||||||||||
| PRIDE | A0FGR8. | ||||||||||||
Protocols and materials databases | |||||||||||||
| DNASU | 57488. | ||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000251527; ENSP00000251527; ENSG00000117868. | ||||||||||||
| GeneID | 57488. | ||||||||||||
| KEGG | hsa:57488. | ||||||||||||
| UCSC | uc003woa.1. human. uc003woc.1. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 57488. | ||||||||||||
| GeneCards | GC07M158523. | ||||||||||||
| H-InvDB | HIX0007266. | ||||||||||||
| HGNC | HGNC:22211. ESYT2. | ||||||||||||
| HPA | HPA002132. | ||||||||||||
| neXtProt | NX_A0FGR8. | ||||||||||||
| PharmGKB | PA165617947. | ||||||||||||
| HUGE | Search... | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | COG5038. | ||||||||||||
| HOVERGEN | HBG055795. | ||||||||||||
| InParanoid | A0FGR8. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | A0FGR8. | ||||||||||||
| Bgee | A0FGR8. | ||||||||||||
| CleanEx | HS_FAM62B. | ||||||||||||
| Genevestigator | A0FGR8. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR000008. C2_Ca-dep. IPR008973. C2_Ca/lipid-bd_dom_CaLB. IPR018029. C2_membr_targeting. [Graphical view] | ||||||||||||
| Pfam | PF00168. C2. 3 hits. [Graphical view] | ||||||||||||
| SMART | SM00239. C2. 3 hits. [Graphical view] | ||||||||||||
| SUPFAM | SSF49562. C2_CaLB. 3 hits. | ||||||||||||
| PROSITE | PS50004. C2. 3 hits. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| ChiTaRS | ESYT2. human. | ||||||||||||
| EvolutionaryTrace | A0FGR8. | ||||||||||||
| GenomeRNAi | 57488. | ||||||||||||
| NextBio | 63768. | ||||||||||||
Entry information
| Entry name | ESYT2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: A0FGR8 Secondary accession number(s): A4D229 Q9ULJ2 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 7 Human chromosome 7: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
